Evidence map›Paper›PMID 25207975›Full record

ArticlePloS one2014

Engineering amyloid-like assemblies from unstructured peptides via site-specific lipid conjugation.

María Pilar López Deber, David T Hickman, Deepak Nand, Marc Baldus, Andrea Pfeifer, Andreas Muhs

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 8 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

María Pilar López DeberAC Immune SA, Lausanne, Switzerland.
David T HickmanAC Immune SA, Lausanne, Switzerland.
Deepak NandBijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.
Marc BaldusBijvoet Center for Biomolecular Research, Utrecht University, Utrecht, The Netherlands.
Andrea PfeiferAC Immune SA, Lausanne, Switzerland.
Andreas MuhsAC Immune SA, Lausanne, Switzerland.
AC Immune (Switzerland) · CHUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aggregation of amyloid beta (Aβ) into oligomers and fibrils is believed to play an important role in the development of Alzheimer's disease (AD). To gain further insight into the principles of aggregation, we have investigated the induction of β-sheet secondary conformation from disordered native peptide sequences through lipidation, in 1-2% hexafluoroisopropanol (HFIP) in phosphate buffered saline (PBS). Several parameters, such as type and number of lipid chains, peptide sequence, peptide length and net charge, were explored keeping the ratio peptide/HFIP constant. The resulting lipoconjugates were characterized by several physico-chemical techniques: Circular Dichroism (CD), Attenuated Total Reflection InfraRed (ATR-IR), Thioflavin T (ThT) fluorescence, Dynamic Light Scattering (DLS), solid-state Nuclear Magnetic Resonance (ssNMR) spectroscopy and Electron Microscopy (EM). Our data demonstrate the generation of β-sheet aggregates from numerous unstructured peptides under physiological pH, independent of the amino acid sequence. The amphiphilicity pattern and hydrophobicity of the scaffold were found to be key factors for their assembly into amyloid-like structures.

Indexed as

Drug DesignLipid MetabolismProtein MultimerizationAmino Acid SequenceAmyloid beta-PeptidesBinding SitesHydrogen-Ion ConcentrationHydrophobic and Hydrophilic InteractionsMolecular Sequence DataProtein Structure, SecondarySubstrate SpecificityWaterAmyloid beta-PeptidesWater

Identifiers

PMID25207975
PMCPMC4160191
OpenAlexW2050307097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.